ShangBay Capital
www.shangbaycapital.comVCMatch tracks ShangBay Capital as an investor focused on Medtech, Biotech, and Healthtech companies, Seed and Series A rounds, and United States and Global markets. Upload your deck to compare your startup against the full private matching profile.
Check Size
Not specified
Focus Areas
Geography
United States and Global
Investment Thesis
ShangBay Capital focuses on identifying and supporting founders building disruptive companies that address high, unmet clinical needs with novel ideas. The firm leverages 100+ years of combined experience from its leadership team to actively partner with entrepreneurs, providing not just capital but deep industry expertise, regulatory knowledge, and an extensive network of strategics, KOLs, and experienced innovators to help portfolio companies commercialize products and scale globally.
Is ShangBay Capital right for your startup?
Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.
Investment Focus
Who should take a closer look
ShangBay Capital is most relevant for founders raising Seed, Series A, and Series B rounds in Medtech, Biotech, Healthtech, and Digital Health, especially across United States and Global.
Focus statement
ShangBay Capital invests in medical devices, biotechnology, and healthcare technology companies that solve significant unmet clinical needs. The firm brings investors access to best-in-class investments through venture equity participation.
Value Add
- #1 most active new device VC from 2020-2023 (per their website)
- #2 most-active healthcare device investor per 2023 HSBC Healthcare Annual Report
- Deep expertise in FDA regulatory pathways and medical device commercialization
- Strong track record: 13 billion-dollar IPOs and 4 M&As among 9 total exits
- Exceptional portfolio financing success: 11 portfolio companies secured new financing in 2023 with no down rounds; 13 portfolio companies received term sheets in 2024
- Comprehensive understanding of global market dynamics and valuation assessment for medical device companies
- Leadership recognized among Top 25 GrowthCap Healthcare Investors (William Dai, 2024)
Stage And Sector Fit
Sectors
Portfolio Highlights
Ceribell
Medical Devices
Lucira Health
Medical Devices
Arrinex
Medical Devices
Apexigen
Biotechnology
Berkeley Lights
Biotechnology
Devoro Medical
Medical Devices
Neurovasc Technologies
Medical Devices
ARANZ Medical
Medical Devices
+ 59 more companies in their portfolio
Investment Team
12 Partners at ShangBay Capital
See who leads investments in your sector and how to connect with them.
Get partner details
Upload your deck to see who's the best fit for your startup.
Ready to find your perfect investor match?
Get Started Free